CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype

This publication has 67 references indexed in Scilit:

• 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
  Oncotarget, 2015
• Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas
  Oncotarget, 2015
• CD24-Triggered Caspase-Dependent Apoptosis via Mitochondrial Membrane Depolarization and Reactive Oxygen Species Production of Human Neutrophils Is Impaired in Sepsis
  The Journal of Immunology, 2014
• Microenvironmental regulation of stem cells in intestinal homeostasis and cancer
  Nature, 2011
• Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
  Journal of Translational Medicine, 2009
• The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
  The Journal of Pathology, 2009
• Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
  Cancer Research, 2009
• Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
  World Journal of Gastroenterology, 2009
• Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
  PLOS ONE, 2008
• Phenotypic characterization of human colorectal cancer stem cells
  Proceedings of the National Academy of Sciences, 2007